April 23 (Reuters) - Water treatment solutions provider

Veralto ( VLTO ) beat Wall Street estimates for quarterly

results on Tuesday, helped by strong demand for its chemical

treatment services and UV filtration systems from customers in

North America.

The company's water quality segment, which provides tests

and analytical measurement tools through the Hach brand and

membrane filtration systems through the Trojan Technologies

brand, has seen strong demand from industrial customers and

municipalities in Europe and North America.

"In our water quality segment, we continue to see positive

secular growth drivers across industrial markets, particularly

in North America, along with steady demand at municipalities."

said CEO Jennifer Honeycutt.

In 2023, the Waltham, Massachusetts-based company generated

roughly 47% of its sales from North America and about 22% from

Western Europe.

Veralto ( VLTO ), which was spun-off from life sciences firm Danaher ( DHR )

in September last year, provides products that help

ensure water quality, and offers packaging and quality control

solutions to businesses in industries including pharmaceutical

and consumer packaged goods.

Veralto ( VLTO ) reported net sales of $1.25 billion for the first

quarter ended March 29, compared with estimates of $1.23

billion.

Its quarterly adjusted earnings of 84 cents per share

also topped analysts' estimate of 76 cents per share.

It also raised its forecast for full-year adjusted profit to

a range of $3.25 to $3.34 per share, from $3.20 to $3.30 per

share estimated previously. Analysts on average expect $3.29 per

share, LSEG data showed.

Shares of the company rose 1.47% in after-hours trading.